pattern anti-carbohydrate antibody responses present patients advanced atherosclerosis pubmed ncbi abstract previously shown antibody pool present normal human serum binds cytokine receptors vitro interfere assays capture cytokines receptors show antibody pool natural antibody termed anti-gal binds alpha-galactosyl carbohydrate epitope alpha-gal predominant obstacle xenotransplantation report high levels igd anti alpha-gal volunteers addition igg num iga igm immunoglobulin isotypes alpha-gal previously determine anti-gal interfere assays depend capture cytokine receptor measured levels anti-carbohydrate antibodies cohort patients advanced atherosclerosis previously measure levels active tgf-beta assay isotype carbohydrate combinations large significant difference levels anti-carbohydrate antibodies patients atherosclerosis controls adjustment age sex blood group results similar previous data obtained active tgf-beta discount possibility anti-gal contributed previous data adjustment risk factors cardiovascular disease anti-carbohydrate antibodies significantly patients controls anti-carbohydrate antibodies represent class risk factors presence advanced atherosclerosis larger studies required confirm hypothesis 
